Brian has long said that health care needs a start, not a finish. With the passage of the 2009 Patient Protection and Affordable Care Act, our nation took a critical first step by giving millions of Americans access to health insurance, including those who had never had access before, like individuals with pre-existing conditions, and making sure that the high cost of medical treatments do not force families into bankruptcy. Brian supports efforts in Congress to come together across the aisle and improve the law, bringing down the cost curve and making the quality of care better for all Americans.
More on Health Care
NEW YORK – Attorney General Eric T. Schneiderman today called on the United States Department of Health and Human Services (HHS) to overturn the Food and Drug Administration’s (FDA) approval of Zohydro Extended Release (Zohydro ER). The Attorney General also issued an open letter to medical professionals highlighting the potential public safety risks posed by Zohydro ER and reminding them that the drug is subject to the restrictions outlined in New York’s historic Internet System for Tracking Over Prescribing Act (I-STOP) legislation, signed into law in 2012.
“I have long said that health care reform needed a start not a finish. We understand the Affordable Care Act isn’t perfect but instead of focusing on ways to improve it we have wasted time with debate entrenched in partisanship that takes us nowhere. Today I was proud to support three pieces of legislation that represent the kind of bipartisan cooperation that we need more of, not message votes or calls for repeal with no plan to replace it.
Congressman Brian Higgins (NY-26) is reporting progress on efforts to reclassify extremely addictive painkillers and address the increasing prescription drug abuse epidemic.
Congressman Brian Higgins (NY-26) recently took to the House of Representatives Floor to raise awareness of the need for a renewed national focus on preventing, treating and caring for those with Alzheimer’s disease.
Today, thousands of advocates from across the country gather in Washington, D.C. to rally in support of medical research funding. The crowd in the nation’s capital will include more than 50 researchers from Roswell Park Cancer Institute.